ES2051712T3 - Procedimiento para producir las composiciones denominadas ll-e19020 alfa y ll-e19020 beta. - Google Patents

Procedimiento para producir las composiciones denominadas ll-e19020 alfa y ll-e19020 beta.

Info

Publication number
ES2051712T3
ES2051712T3 ES87109199T ES87109199T ES2051712T3 ES 2051712 T3 ES2051712 T3 ES 2051712T3 ES 87109199 T ES87109199 T ES 87109199T ES 87109199 T ES87109199 T ES 87109199T ES 2051712 T3 ES2051712 T3 ES 2051712T3
Authority
ES
Spain
Prior art keywords
beta
alfa
procedure
produce
compositions called
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87109199T
Other languages
English (en)
Inventor
Guy Thomas Carter
Michael Greenstein
Joseph Jacob Goodman
Donald Bruce Borders
William Michael Maiese
Raymond Thomas Testa
Irwin Boyden Wood
Mary Eulers Doscher
Sidney Kantor
Robert Lee Kennett Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/880,608 external-priority patent/US4704276A/en
Priority claimed from US06/880,229 external-priority patent/US4753798A/en
Priority claimed from US06/880,230 external-priority patent/US4705688A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2051712T3 publication Critical patent/ES2051712T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00—Antibiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Animal Husbandry (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A LOS ANTIBIOTICOS LL-E 19020 ALFA Y LL-19020 BETA DERIVADOS DEL MICROORGANISMO STREPTOMYCES LYDICUS, SUBESPECIE TANZANIUS NRRL 18036, QUE SON UTILES COMO AGENTES ANTIBACTERIANOS. LOS ANTIBIOTICOS LL-E 19020 ALFA Y LL-E 19020 BETA SON TAMBIEN PROMOTORES DE CRECIMIENTO, AGENTES ANTIPROTOZOARIOS Y AGENTES ANTIHELMINTICOS.
ES87109199T 1986-06-30 1987-06-26 Procedimiento para producir las composiciones denominadas ll-e19020 alfa y ll-e19020 beta. Expired - Lifetime ES2051712T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US88023986A 1986-06-30 1986-06-30
US06/880,608 US4704276A (en) 1986-06-30 1986-06-30 Compositions and methods for increasing the growth rate of meat producing animals, improving the efficiency of feed utilization thereby and enhancing lactation in lactating ruminants
US06/880,229 US4753798A (en) 1986-06-30 1986-06-30 Methods and compositions for controlling protozoal infections in warm-blooded animals
US06/880,230 US4705688A (en) 1986-06-30 1986-06-30 Antibiotic LL-E19020 α and β

Publications (1)

Publication Number Publication Date
ES2051712T3 true ES2051712T3 (es) 1994-07-01

Family

ID=27505969

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87109199T Expired - Lifetime ES2051712T3 (es) 1986-06-30 1987-06-26 Procedimiento para producir las composiciones denominadas ll-e19020 alfa y ll-e19020 beta.

Country Status (11)

Country Link
EP (1) EP0252380B1 (es)
JP (2) JP2535544B2 (es)
KR (1) KR950000983B1 (es)
CA (1) CA1338168C (es)
DE (1) DE3778225D1 (es)
DK (1) DK170282B1 (es)
ES (1) ES2051712T3 (es)
GR (1) GR3004369T3 (es)
IE (1) IE60758B1 (es)
IL (1) IL83025A (es)
NZ (1) NZ220900A (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3889417T2 (de) * 1987-10-29 1994-12-01 American Cyanamid Co Methode für die Kontrolle von chronischer Atmungskrankheit und nekrotischer Enteritis bei Vögeln.
US5204361A (en) * 1988-03-30 1993-04-20 Rowe James B Method for treating laminitis in equine livestock
US5077277A (en) * 1989-09-05 1991-12-31 American Cyanamid Company Chemical derivatives of antibiotics ll-e19020 alpha and beta
FR2657873B1 (fr) * 1990-02-08 1992-04-17 Rhone Poulenc Sante Nouvelle elfamycine, son procede de preparation et son utilisation.
US5814615A (en) * 1991-09-09 1998-09-29 Roche Vitamins Inc. Antibiotic LL-E19020 Alpha1
WO1993013217A1 (en) * 1991-12-27 1993-07-08 Gruppo Lepetit S.P.A. Antibiotic ge 21640a
KR100404067B1 (ko) * 2001-01-04 2003-11-01 주식회사 이지바이오시스템 유기태 셀레늄 함유 홍보리쌀 및 그의 제조방법
US7247299B2 (en) * 2002-11-27 2007-07-24 Kemin Industries, Inc. Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens

Also Published As

Publication number Publication date
KR950000983B1 (en) 1995-02-06
IL83025A0 (en) 1987-12-20
JPH08205856A (ja) 1996-08-13
JPS6366191A (ja) 1988-03-24
EP0252380A2 (en) 1988-01-13
DK170282B1 (da) 1995-07-24
CA1338168C (en) 1996-03-19
IE871731L (en) 1987-12-30
DE3778225D1 (de) 1992-05-21
EP0252380A3 (en) 1988-09-14
JP2535544B2 (ja) 1996-09-18
JP2572562B2 (ja) 1997-01-16
DK332287D0 (da) 1987-06-29
AU596672B2 (en) 1990-05-10
DK332287A (da) 1987-12-31
AU7490187A (en) 1988-01-07
NZ220900A (en) 1990-09-26
EP0252380B1 (en) 1992-04-15
IE60758B1 (en) 1994-08-10
KR880000457A (ko) 1988-03-26
GR3004369T3 (es) 1993-03-31
IL83025A (en) 1992-01-15

Similar Documents

Publication Publication Date Title
ES2052574T3 (es) Antibioticos glicopeptidos.
BR1100989A (pt) Composto e composição de matéria
ES2131496T3 (es) Mejoras relativas a derivados glicopeptidicos.
ES475854A1 (es) Un procedimiento para preparar derivados de glicosido de pleuromutilina
MX16158A (es) Un procedimiento para la preparacion de derivados aromaticos y heterociclicos de carboxiamida, utiles como agentes antitumorales
SE8002601L (sv) Antibiotikum a/16686 och forfarande for framstellning derav
ES2051712T3 (es) Procedimiento para producir las composiciones denominadas ll-e19020 alfa y ll-e19020 beta.
ES2055719T3 (es) Derivados de desmanosil-teicoplanina.
ES2168276T3 (es) 1-arilsulfonil-3-fenil-1,4,5,6-tetrahidropiridazinas.
SE8502135D0 (sv) 4'-deschlororebeccamycin and process for its preparation
DK4481A (da) Hydroxyalkylstivelse som laegemiddelbaerer
DE3872063D1 (de) Zusammensetzung mit anregender wirkung fuer die haare.
ES2143004T3 (es) Derivados de la milbemicina, su preparacion y uso.
NO874948D0 (no) Lakton-nedbrytningsprodukter.
ES2115424T3 (es) Derivados prolin-amidicos basicos de los antibioticos ge 2270 y similares a ge 2270.
ES2038127T3 (es) Procedimiento para preparar monosulfactamas.
ATE79373T1 (de) Beta-alkylmelatonine.
PT80939B (pt) Processo para a preparacao de novas composicoes de pre-mistura anticoccidicas. antibioticas, de polieter ionoforo
SE7703760L (sv) Antibiotika
ES548789A0 (es) Un procedimiento para preparar derivados esteres del antibiotico l 17046.
MX9102290A (es) Estereoisomeros individuales de 7-(3-1-aminoalquil)-1-pirrolidinil)-quinolonas y naftiridonas,como agentes antibacterianos
DK211289D0 (da) Polyether-antibiotikum benaevnt a82810 og fremgangsmaade til fremstilling deraf
ES2059791T3 (es) Antibiotico a80915 y procedimiento para su produccion.
ES467067A1 (es) Procedimiento para la preparacion de compuestos promotores de secrecion de insulina.
DE3785868D1 (de) Tierwachstum foerdernde mittel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 252380

Country of ref document: ES